Medical News

RSS

Researchers discover protein that may open door to new method of treating type 2 diabetes

The STK25 protein contributes to cell growth. Researchers at Sahlgrenska Academy have discovered that the protein also affects metabolism, demonstrating that elevated levels accelerate the progress of diabetes in mice.

3 Sep 2014

EPA should lower safe fluoride level goal in public drinking water systems to zero

New evidence indicating that EPA should lower its safe fluoride level goal in public drinking water systems to zero, will be presented by former EPA senior risk assessment scientist, William Hirzy PhD, at the Fluoride Action Network's (FAN) 5th Citizens' Conference and Lobby Day on Fluoride, September 5 – 8, at the Crystal City Hyatt Regency Hotel in Crystal City, VA. A press conference on September 5 will provide a preview (details below).

3 Sep 2014

Bypassing politics, insurers pay for end of life talks

These doctor-patient conversations had been labeled "death panels" by opponents of the Affordable Care Act. Meanwhile, in a bid to reduce backlogs, Medicare offers a deal to hospitals to pay 68 percent of short-term stay medical claims that were rejected by outside auditors.

3 Sep 2014

Many nurses in training feel unprepared to meet patients during end-of-life care

Most nurses in their work care for patients who are dying. A study of more than 200 students has shown that many nurses in training feel unprepared and anxious when faced with the prospect of meeting patients during end-of-life care.

3 Sep 2014

More than 1/3 of planned orthopaedic surgery procedures are re-booked

More than one third of all planned orthopaedic surgery procedures are re-booked, postponed or cancelled completely.

3 Sep 2014

Researchers create new drug to reduce inflammation of donor organ after transplantation

To reduce the number of discards and thus make more kidneys available, researchers and medical scientists from the European consortium MABSOT have created a new drug called OPN-305 to reduce inflammation of the donor organ after transplantation.

3 Sep 2014

Researchers identify enzyme that controls spread of breast cancer

Researchers at the University of California, San Diego School of Medicine have identified an enzyme that controls the spread of breast cancer. The findings, reported in the current issue of PNAS, offer hope for the leading cause of breast cancer mortality worldwide.

2 Sep 2014

ANP reports primary efficacy results from ATL1103 Phase II trial in patients with acromegaly

Antisense Therapeutics Limited is pleased to report the primary efficacy results from its Phase II clinical trial of ATL1103 in patients with the potentially life threatening growth disorder, acromegaly.

2 Sep 2014

More big firms shifting to high-deductible health plans

The New York Times examines the movement among large employers towards high-deductible plans that shift more health care costs to workers. Meanwhile, The Wall Street Journal looks at how the ACA may affect job-based plans next year.

2 Sep 2014

Aviv acquires assisted living and skilled nursing facilities for $83.6 million

Aviv REIT, Inc. announced today it acquired four post-acute and long-term care skilled nursing facilities ("SNF") in Washington, an assisted living facility ("ALF") in Washington and a campus in Idaho, which includes a SNF and an ALF, for a total price of $83.6 million.

2 Sep 2014

Organizations across U.S. participating in Go Gold for Childhood Cancer Awareness campaign

Organizations in Atlanta – and across the country – are participating in the Go Gold for Childhood Cancer Awareness campaign this September. Coordinating this effort is the Aflac Cancer Center of Children's Healthcare of Atlanta along with the Stop Childhood Cancer Alliance that was created to be the driving force in increasing awareness of childhood cancer and enhancing support for the young people fighting this disease, as well as the clinicians and researchers helping them.

2 Sep 2014

XBiotech reports interim results from Phase III study for anti-cancer agent Xilonix

XBiotech announced today interim results from its fast-tracked Phase III study being conducted in the US for its anti-cancer agent Xilonix.

2 Sep 2014

BioPhotas launches Celluma ELITE for sale to Aesthetic Physician Market

BioPhotas, Inc. today announced the launch of the Celluma ELITE for sale to the Aesthetic Physician Market. The LED therapy device is stand-mounted and able to be precisely positioned over an area of treatment via an articulating arm and a patented shape-taking light panel.

2 Sep 2014

Nomination signals new approach to drug abuse policy

The nomination of Michael Botticelli to head the Office of National Drug Control Policy symbolizes the shift toward dealing with drug use as a public health rather than as a criminal justice issue, writes The Washington Post. Reuters looks at how opioid abuse fears keep cancer patients from getting pain relief.

2 Sep 2014

BioLegend acquires shares of Covance Antibody Services

BioLegend, Inc. (BioLegend) acquired the shares of Covance Antibody Services Inc., a business unit of Covance, located in Dedham, Massachusetts, on August 29, 2014.

From BioLegend 2 Sep 2014

Amgen seeks EMA approval for marketing talimogene laherparepvec

Amgen today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) via the centralized procedure for talimogene laherparepvec seeking approval for the treatment of adults with melanoma that is regionally or distantly metastatic.

2 Sep 2014

MEI Pharma completes patient enrollment in Pracinostat Phase II trial for treatment of MDS

MEI Pharma, Inc., an oncology company focused on the clinical development of novel therapies for cancer, announced today that it has completed enrollment in a randomized Phase II clinical trial of its lead investigational drug candidate Pracinostat in combination with azacitidine in patients with previously untreated intermediate-2 or high-risk myelodysplastic syndrome (MDS).

2 Sep 2014

Travel time to breast imaging services in United States varies dramatically by modality

Mammography, ultrasound, and MRI - or a combination of these examinations - are critical in detecting, diagnosing, and characterizing the extent of breast cancer.

2 Sep 2014

VentiRx's motolimod receives FDA Fast Track designation for ovarian cancer treatment

VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of motolimod (VTX-2337) when administered in combination with pegylated liposomal doxorubicin (PLD) for the treatment of women with ovarian cancer whose disease has progressed on or recurred after platinum-based chemotherapy.

2 Sep 2014

Coffee increases risk of prediabetes in young adults with hypertension

Coffee increases the risk of prediabetes in young adults with hypertension who are slow caffeine metabolisers, according to results from the HARVEST study presented at ESC Congress today by Dr Lucio Mos from Italy. People who drank more than three cups of coffee per day doubled their risk of prediabetes.

2 Sep 2014

Medical News

Researchers discover protein that may open door to new method of treating type 2 diabetes

EPA should lower safe fluoride level goal in public drinking water systems to zero

Bypassing politics, insurers pay for end of life talks

Many nurses in training feel unprepared to meet patients during end-of-life care

More than 1/3 of planned orthopaedic surgery procedures are re-booked

Researchers create new drug to reduce inflammation of donor organ after transplantation

Researchers identify enzyme that controls spread of breast cancer

ANP reports primary efficacy results from ATL1103 Phase II trial in patients with acromegaly

More big firms shifting to high-deductible health plans

Aviv acquires assisted living and skilled nursing facilities for $83.6 million

Organizations across U.S. participating in Go Gold for Childhood Cancer Awareness campaign

XBiotech reports interim results from Phase III study for anti-cancer agent Xilonix

BioPhotas launches Celluma ELITE for sale to Aesthetic Physician Market

Nomination signals new approach to drug abuse policy

BioLegend acquires shares of Covance Antibody Services

Amgen seeks EMA approval for marketing talimogene laherparepvec

MEI Pharma completes patient enrollment in Pracinostat Phase II trial for treatment of MDS

Travel time to breast imaging services in United States varies dramatically by modality

VentiRx's motolimod receives FDA Fast Track designation for ovarian cancer treatment

Coffee increases risk of prediabetes in young adults with hypertension

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News